Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03083691
Title BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer
Recruitment Enrolling by invitation
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Lung Cancer Group Cologne

lung small cell carcinoma

lung non-squamous non-small cell carcinoma


Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST